Survival outcomes for patients with localised upper tract urothelial carcinoma managed with non-definitive treatment.
Jamil S SyedKevin A NguyenAlfredo Suarez-SarmientoKatelyn JohnsonMichael S LeapmanJay D RamanBrian ShuchPublished in: BJU international (2017)
In this population-based cohort, 7.6% of patients with UTUC were managed with a non-definitive approach. The median OS for the untreated cohort was significantly shorter compared to the surgical cohort (1.9 vs 7.8 years, respectively). These data may be helpful in counselling patients who are poor surgical candidates, as non-definitive therapy may provide reasonable oncological outcomes.
Keyphrases
- locally advanced
- end stage renal disease
- ejection fraction
- newly diagnosed
- rectal cancer
- prognostic factors
- peritoneal dialysis
- stem cells
- squamous cell carcinoma
- metabolic syndrome
- smoking cessation
- type diabetes
- mesenchymal stem cells
- combination therapy
- minimally invasive
- hiv infected
- replacement therapy
- hiv testing
- men who have sex with men